8-K 1 e15285_8k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ------------ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2003 BIOSITE INCORPORATED -------------------- (Exact name of registrant as specified in its charter) Delaware 000-21873 33-0288606 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 11030 Roselle Street, San Diego, California 92121 ------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (858) 455-4808 ITEM 7 Financial Statements and Exhibits. (c) Exhibits. Exhibit 99.1 Press release of Biosite Incorporated dated July 24, 2003 ITEM 9 REGULATION FD DISCLOSURE (Information furnished pursuant to Item 12, "Disclosure of Results of Operations and Financial Condition"). On July 24, 2003, Biosite Incorporated issued an earnings release announcing its financial results for the second quarter ended June 30, 2003. A copy of the earnings release is attached as Exhibit 99.1 to this Form 8-K. The information contained in this Item 9 of this Current Report is being furnished pursuant to "Item 12. Results of Operations and Financial Condition" of Form 8-K in accordance with SEC Release No. 33-8216. The information in this Current Report and attached Exhibit are being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report and attached Exhibit shall not be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: July 24, 2003 BIOSITE INCORPORATED By /s/ Christopher J. Twomey --------------------------------- Christopher J. Twomey Vice President, Finance and Chief Financial Officer -3- INDEX TO EXHIBITS Exhibit Number Exhibit ------- ------- Exhibit 99.1 Press release of Biosite Incorporated dated July 24, 2003 -4-